Persistent Asset Partners Ltd
13F Reported Value
ⓘ$268.3M
incl. option notional
Equity Holdings
ⓘ$257.5M
Option Notional
ⓘ$10.8M
$2.9M puts / $7.9M calls
Holdings
322
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Persistent Asset Partners Ltd disclosed 322 positions worth $268.3M in its Form 13F-HR for Q1 2026 — $257.5M in common stock plus $10.8M of put/call option positions (reported at underlying notional value, not premium at risk), led by $LITE (Lumentum Holdings Inc.) at 5.6% of the equity portfolio, followed by $AXTI and $INTC. During the quarter the fund opened 146 new positions and exited 186 — including a new stake in $TSEM and a full exit from $CNC. The portfolio is most concentrated in Technology (46.5% of disclosed assets). All figures are sourced directly from Persistent Asset Partners Ltd’s Form 13F-HR filing with the SEC under CIK 2056052.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 63.4#685
Quality
$14.5M20,673 sh - 30.9#2,337
Quality
$13.3M233,563 sh - 41.5#1,892
Quality
$12.1M274,389 sh - —
Quality
$11.9M67,608 sh - 88.8
Quality
$9.1M14,280 sh - 72.7
Quality
$8.0M59,088 sh - 90.2
Quality
$7.0M39,936 sh - 88.4
Quality
$5.6M16,550 sh - 70.7
Quality
$4.6M11,838 sh - —
Quality
$4.3M133,066 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 63.4#685 | $14.5M | 20,673 | |
| 30.9#2,337 | $13.3M | 233,563 | |
| 41.5#1,892 | $12.1M | 274,389 | |
| — | $11.9M | 67,608 | |
| 88.8 | $9.1M | 14,280 | |
| 72.7 | $8.0M | 59,088 | |
| 90.2 | $7.0M | 39,936 | |
| 88.4 | $5.6M | 16,550 | |
| 70.7 | $4.6M | 11,838 | |
| — | $4.3M | 133,066 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Persistent Asset Partners Ltd's 322 positions.
Showing top 10 of 322 holdings.
Sector Allocation
Technology
$119.9M
Healthcare
$78.0M
Financials
$24.2M
Materials
$17.1M
Industrials
$9.4M
Energy
$3.0M
Consumer Discretionary
$2.9M
Consumer Staples
$1.0M
Full Holdings — Persistent Asset Partners Ltd (Q1 2026)
All 322 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Lumentum Holdings Inc. | $14.5M | 5.6% | +265% | 63.4 | |
| 2 | AXT INC | $13.3M | 5.2% | -24% | 30.9 | |
| 3 | INTEL CORP | $12.1M | 4.7% | +89% | 41.5 | |
| 4 | TOWER SEMICONDUCTOR LTD | $11.9M | 4.6% | NEW | — | |
| 5 | Sandisk Corp | $9.1M | 3.5% | -21% | 88.8 | |
| 6 | CORNING INC /NY | $8.0M | 3.1% | +1020% | 72.7 | |
| 7 | NVIDIA CORP | $7.0M | 2.7% | +144% | 90.2 | |
| 8 | MICRON TECHNOLOGY INC | $5.6M | 2.2% | +199% | 88.4 | |
| 9 | CIENA CORP | $4.6M | 1.8% | NEW | 70.7 | |
| 10 | Viking Therapeutics, Inc. | $4.3M | 1.7% | +47% | — | |
| 11 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $4.2M | 1.6% | +680% | — | |
| 12 | UNITED THERAPEUTICS Corp | $4.1M | 1.6% | +111% | 80.1 | |
| 13 | Astera Labs, Inc. | $3.7M | 1.4% | NEW | 77.7 | |
| 14 | Cogent Biosciences, Inc. | $3.6M | 1.4% | +95% | — | |
| 15 | MACOM Technology Solutions Holdings, Inc. | $3.5M | 1.4% | NEW | 70.6 | |
| 16 | JOHNSON & JOHNSON | $3.3M | 1.3% | -23% | 72.8 | |
| 17 | TERADYNE, INC | $3.3M | 1.3% | NEW | 74.6 | |
| 18 | COHERENT CORP. | $3.3M | 1.3% | +1863% | 64 | |
| 19 | Jazz Pharmaceuticals plc | $3.0M | 1.2% | +741% | — | |
| 20 | TE Connectivity plc | $2.8M | 1.1% | NEW | — | |
| 21 | Alphabet Inc. | $2.8M | 1.1% | +20% | 80.2 | |
| 22 | NexGen Energy Ltd. | $2.8M | 1.1% | -2% | — | |
| 23 | MODINE MANUFACTURING CO | $2.7M | 1.1% | +240% | 48.8 | |
| 24 | Abivax S.A. | $2.5M | 1.0% | -6% | — | |
| 25 | Revolution Medicines, Inc. | $2.5M | 1.0% | +49% | — | |
| 26 | Terns Pharmaceuticals, Inc. | $2.4M | 0.9% | -60% | — | |
| 27 | SEMTECH CORP | $2.4M | 0.9% | NEW | 54.5 | |
| 28 | Qorvo, Inc. | $2.3M | 0.9% | NEW | 64.3 | |
| 29 | BIOMARIN PHARMACEUTICAL INC | $2.1M | 0.8% | -4% | 74.1 | |
| 30 | Axos Financial, Inc. | $2.0M | 0.8% | +898% | 34.3 | |
| 31 | Kodiak Sciences Inc. | $2.0M | 0.8% | NEW | — | |
| 32 | Apogee Therapeutics, Inc. | $1.9M | — | +0% | — | |
| 33 | Nebius Group N.V. | $1.9M | 0.7% | -39% | — | |
| 34 | COASTAL FINANCIAL CORP | $1.9M | 0.7% | +60% | — | |
| 35 | INCYTE CORP | $1.9M | 0.7% | NEW | 81.2 | |
| 36 | ELDORADO GOLD CORP /FI | $1.8M | 0.7% | +4% | — | |
| 37 | BridgeBio Pharma, Inc. | $1.8M | 0.7% | +27% | 31.7 | |
| 38 | TG THERAPEUTICS, INC. | $1.8M | 0.7% | +60% | 68.4 | |
| 39 | ELI LILLY & Co | $1.8M | 0.7% | +258% | 89.3 | |
| 40 | Equinox Gold Corp. | $1.7M | 0.7% | +5% | — | |
| 41 | CVB FINANCIAL CORP | $1.6M | 0.6% | +203% | — | |
| 42 | SailPoint, Inc. | $1.6M | 0.6% | +72% | 29.5 | |
| 43 | Viking Therapeutics, Inc. | $1.5M | — | -9% | — | |
| 44 | PDD Holdings Inc. | $1.5M | 0.6% | -10% | — | |
| 45 | Trekor Metals Ltd | $1.5M | 0.6% | -11% | — | |
| 46 | Immunocore Holdings plc | $1.5M | 0.6% | +75% | — | |
| 47 | EXPAND ENERGY Corp | $1.5M | 0.6% | +56% | 83.9 | |
| 48 | Marvell Technology, Inc. | $1.5M | 0.6% | NEW | 77.3 | |
| 49 | CMB.TECH NV | $1.4M | 0.5% | +102% | — | |
| 50 | AbbVie Inc. | $1.3M | 0.5% | NEW | 59.3 | |
| 51 | Enova International, Inc. | $1.3M | 0.5% | +1501% | 76.8 | |
| 52 | Arcus Biosciences, Inc. | $1.3M | 0.5% | NEW | 12 | |
| 53 | ServisFirst Bancshares, Inc. | $1.2M | 0.5% | NEW | — | |
| 54 | Flutter Entertainment plc | $1.2M | 0.5% | NEW | — | |
| 55 | CRH PUBLIC LTD CO | $1.2M | 0.5% | NEW | — | |
| 56 | Amcor plc | $1.2M | 0.5% | NEW | — | |
| 57 | COLUMBIA BANKING SYSTEM, INC. | $1.2M | 0.5% | +20% | 33 | |
| 58 | Ameris Bancorp | $1.1M | 0.4% | +37% | — | |
| 59 | Tesla, Inc. | $1.1M | 0.4% | NEW | 50.1 | |
| 60 | TripAdvisor, Inc. | $1.1M | 0.4% | +0% | 51.5 | |
| 61 | Corbus Pharmaceuticals Holdings, Inc. | $1.0M | 0.4% | +1589% | — | |
| 62 | QCR HOLDINGS INC | $999,167 | 0.4% | +39% | — | |
| 63 | CAPRICOR THERAPEUTICS, INC. | $998,962 | — | +0% | — | |
| 64 | Roblox Corp | $991,440 | 0.4% | -12% | 53.7 | |
| 65 | Nu Holdings Ltd. | $965,147 | 0.4% | NEW | — | |
| 66 | NEWS CORP | $960,103 | 0.4% | +9% | 62.4 | |
| 67 | SPROTT INC. | $959,431 | 0.4% | -4% | — | |
| 68 | CARVANA CO. | $943,140 | 0.4% | NEW | 69.2 | |
| 69 | CITIGROUP INC | $934,385 | 0.4% | -12% | 54.8 | |
| 70 | TENAX THERAPEUTICS, INC. | $930,330 | 0.4% | -11% | — | |
| 71 | Rocket Companies, Inc. | $920,735 | 0.4% | NEW | — | |
| 72 | Corvus Pharmaceuticals, Inc. | $907,806 | 0.3% | NEW | — | |
| 73 | Alkermes plc. | $903,908 | 0.3% | NEW | — | |
| 74 | Zymeworks Inc. | $899,812 | 0.3% | +389% | 27.2 | |
| 75 | SouthState Bank Corp | $887,729 | 0.3% | +37% | — | |
| 76 | STIFEL FINANCIAL CORP | $886,596 | 0.3% | +7% | 69.6 | |
| 77 | Structure Therapeutics Inc. | $880,277 | 0.3% | +650% | — | |
| 78 | First Western Financial Inc | $848,502 | 0.3% | -8% | 53.1 | |
| 79 | Triumph Financial, Inc. | $846,754 | 0.3% | NEW | — | |
| 80 | — | NORTHEAST BK PORTLAND ME | $846,034 | 0.3% | -36% | — |
| 81 | AKAMAI TECHNOLOGIES INC | $841,161 | 0.3% | NEW | 62 | |
| 82 | PATHWARD FINANCIAL, INC. | $834,657 | 0.3% | -9% | 69.9 | |
| 83 | Bitdeer Technologies Group | $803,282 | 0.3% | NEW | — | |
| 84 | CG Oncology, Inc. | $787,728 | 0.3% | -6% | 28 | |
| 85 | Monte Rosa Therapeutics, Inc. | $781,375 | 0.3% | +114% | 18.1 | |
| 86 | EyePoint, Inc. | $760,446 | 0.3% | +995% | 10.3 | |
| 87 | Inventiva S.A. | $710,950 | 0.3% | -1% | — | |
| 88 | ABBOTT LABORATORIES | $696,000 | 0.3% | NEW | 67 | |
| 89 | Canadian Solar Inc. | $692,500 | 0.3% | NEW | — | |
| 90 | NORTHPOINTE BANCSHARES INC | $688,243 | 0.3% | +113% | — | |
| 91 | Kanzhun Ltd | $669,500 | 0.3% | NEW | — | |
| 92 | Harmony Biosciences Holdings, Inc. | $659,579 | 0.3% | +126% | 75.3 | |
| 93 | Figure Technology Solutions, Inc. | $651,467 | 0.3% | NEW | — | |
| 94 | Interactive Brokers Group, Inc. | $643,537 | 0.3% | NEW | 75.5 | |
| 95 | Dianthus Therapeutics, Inc. /DE/ | $624,533 | 0.2% | -24% | 26.8 | |
| 96 | CAPRICOR THERAPEUTICS, INC. | $605,963 | 0.2% | -61% | — | |
| 97 | Edgewise Therapeutics, Inc. | $591,008 | — | NEW | — | |
| 98 | Qnity Electronics, Inc. | $590,053 | 0.2% | NEW | — | |
| 99 | FIRST SOLAR, INC. | $586,607 | 0.2% | +708% | 73.8 | |
| 100 | DARLING INGREDIENTS INC. | $583,053 | 0.2% | -36% | 46.6 | |
| 101 | Veradermics, Inc | $580,412 | 0.2% | NEW | — | |
| 102 | MINISO Group Holding Ltd | $559,273 | 0.2% | -5% | — | |
| 103 | BICYCLE THERAPEUTICS PLC | $558,828 | 0.2% | NEW | — | |
| 104 | Edwards Lifesciences Corp | $553,753 | 0.2% | +20% | 67.6 | |
| 105 | Celcuity Inc. | $552,780 | 0.2% | -28% | — | |
| 106 | Indivior Pharmaceuticals, Inc. | $549,006 | 0.2% | +298% | 64.6 | |
| 107 | RANGE RESOURCES CORP | $542,228 | 0.2% | NEW | 82.8 | |
| 108 | Climb Bio, Inc. | $495,426 | 0.2% | +684% | — | |
| 109 | Rubrik, Inc. | $489,700 | 0.2% | -38% | 49.5 | |
| 110 | Tango Therapeutics, Inc. | $483,587 | 0.2% | NEW | 26.9 | |
| 111 | Frontline plc | $479,540 | 0.2% | NEW | — | |
| 112 | Sanofi | $479,198 | 0.2% | +34% | — | |
| 113 | Shattuck Labs, Inc. | $477,292 | 0.2% | NEW | — | |
| 114 | Anteris Technologies Global Corp. | $476,817 | 0.2% | +268% | — | |
| 115 | SIMILARWEB LTD. | $469,800 | 0.2% | +0% | — | |
| 116 | Amerant Bancorp Inc. | $460,063 | 0.2% | -42% | — | |
| 117 | Tarsus Pharmaceuticals, Inc. | $459,903 | 0.2% | NEW | 40.8 | |
| 118 | Erasca, Inc. | $457,409 | 0.2% | NEW | — | |
| 119 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $455,918 | 0.2% | +26% | 47.1 | |
| 120 | International Seaways, Inc. | $451,399 | 0.2% | +218% | 64.9 | |
| 121 | INTUITIVE SURGICAL INC | $450,387 | 0.2% | +0% | 81.4 | |
| 122 | MACROGENICS INC | $438,494 | 0.2% | NEW | 31.7 | |
| 123 | VERTEX PHARMACEUTICALS INC / MA | $419,301 | 0.2% | -65% | 76.6 | |
| 124 | NEKTAR THERAPEUTICS | $418,749 | 0.2% | NEW | 10.2 | |
| 125 | Mineralys Therapeutics, Inc. | $417,213 | 0.2% | +108% | — | |
| 126 | PALISADE BIO, INC. | $413,609 | 0.2% | -43% | — | |
| 127 | Voyager Therapeutics, Inc. | $413,383 | 0.2% | NEW | 5.5 | |
| 128 | Kodiak Sciences Inc. | $410,501 | — | NEW | — | |
| 129 | INCYTE CORP | $382,093 | — | +0% | 81.2 | |
| 130 | Cencora, Inc. | $381,994 | 0.1% | +9% | 59.6 | |
| 131 | Compass Therapeutics, Inc. | $381,901 | 0.1% | +26% | — | |
| 132 | ICON PLC | $377,683 | 0.1% | +38% | — | |
| 133 | Guardant Health, Inc. | $377,424 | 0.1% | NEW | 36.1 | |
| 134 | STRYKER CORP | $364,735 | 0.1% | +107% | 69.8 | |
| 135 | Praxis Precision Medicines, Inc. | $364,397 | 0.1% | -20% | — | |
| 136 | ANTERO RESOURCES Corp | $358,307 | 0.1% | NEW | 80.1 | |
| 137 | RELMADA THERAPEUTICS, INC. | $353,380 | 0.1% | -78% | — | |
| 138 | BIOGEN INC. | $348,877 | 0.1% | -34% | 65.6 | |
| 139 | uniQure N.V. | $345,192 | — | +0% | — | |
| 140 | Jefferson Capital, Inc. / DE | $341,813 | 0.1% | NEW | 46.6 | |
| 141 | NOVO NORDISK A S | $338,756 | — | +0% | — | |
| 142 | Trevi Therapeutics, Inc. | $333,002 | 0.1% | -39% | — | |
| 143 | Mirum Pharmaceuticals, Inc. | $330,720 | 0.1% | -65% | 32.7 | |
| 144 | Abivax S.A. | $325,320 | — | NEW | — | |
| 145 | UMB FINANCIAL CORP | $324,722 | 0.1% | NEW | — | |
| 146 | Vaxcyte, Inc. | $323,314 | — | NEW | — | |
| 147 | PBF Energy Inc. | $322,761 | 0.1% | NEW | 42.1 | |
| 148 | LivaNova PLC | $318,054 | 0.1% | +28% | — | |
| 149 | Live Oak Bancshares, Inc. | $317,307 | 0.1% | +105% | — | |
| 150 | Edgewise Therapeutics, Inc. | $316,670 | 0.1% | -53% | — | |
| 151 | ConnectOne Bancorp, Inc. | $313,075 | 0.1% | -64% | — | |
| 152 | Vaxcyte, Inc. | $309,087 | 0.1% | -0% | — | |
| 153 | REGENERON PHARMACEUTICALS, INC. | $309,056 | 0.1% | -85% | 75.1 | |
| 154 | DEXCOM INC | $301,503 | 0.1% | +33% | 77.9 | |
| 155 | Definium Therapeutics, Inc. | $299,773 | 0.1% | NEW | — | |
| 156 | Phathom Pharmaceuticals, Inc. | $297,371 | 0.1% | +107% | 32.5 | |
| 157 | HUMANA INC | $289,041 | 0.1% | NEW | 82 | |
| 158 | Abivax S.A. | $288,425 | — | NEW | — | |
| 159 | Medtronic plc | $281,266 | 0.1% | -35% | — | |
| 160 | Beacon Financial Corp | $280,620 | 0.1% | NEW | 46.9 | |
| 161 | ZILLOW GROUP, INC. | $275,467 | 0.1% | -41% | 57.3 | |
| 162 | EUPRAXIA PHARMACEUTICALS INC. | $274,584 | 0.1% | NEW | — | |
| 163 | SAB Biotherapeutics, Inc. | $267,074 | 0.1% | +252% | — | |
| 164 | BioAge Labs, Inc. | $265,271 | 0.1% | -79% | 28.6 | |
| 165 | Maze Therapeutics, Inc. | $261,725 | 0.1% | +33% | 19.7 | |
| 166 | POWER SOLUTIONS INTERNATIONAL, INC. | $261,480 | 0.1% | NEW | 75 | |
| 167 | Enliven Therapeutics, Inc. | $258,955 | 0.1% | NEW | — | |
| 168 | Full Truck Alliance Co. Ltd. | $255,731 | 0.1% | NEW | — | |
| 169 | AYTU BIOPHARMA, INC | $253,609 | 0.1% | +17% | 21.5 | |
| 170 | Sea Ltd | $248,430 | 0.1% | -40% | — | |
| 171 | Royalty Pharma plc | $248,389 | 0.1% | -21% | — | |
| 172 | INOVIO PHARMACEUTICALS, INC. | $247,365 | 0.1% | +0% | — | |
| 173 | THERMO FISHER SCIENTIFIC INC. | $247,240 | 0.1% | +9% | 63.7 | |
| 174 | Annexon, Inc. | $245,294 | — | +8% | — | |
| 175 | ASTRAZENECA PLC | $243,764 | 0.1% | NEW | — | |
| 176 | Spyre Therapeutics, Inc. | $242,263 | 0.1% | +114% | — | |
| 177 | DBV Technologies S.A. | $237,979 | 0.1% | +89% | 6.1 | |
| 178 | Replimune Group, Inc. | $237,468 | — | NEW | — | |
| 179 | Adlai Nortye Ltd. | $233,425 | 0.1% | NEW | — | |
| 180 | Zai Lab Ltd | $232,097 | 0.1% | +0% | — | |
| 181 | CoreWeave, Inc. | $224,043 | 0.1% | NEW | 46.5 | |
| 182 | New Oriental Education & Technology Group Inc. | $224,028 | 0.1% | -67% | — | |
| 183 | Pharvaris N.V. | $223,288 | 0.1% | NEW | — | |
| 184 | SEADRILL Ltd | $222,997 | 0.1% | NEW | — | |
| 185 | Foghorn Therapeutics Inc. | $222,959 | 0.1% | -1% | 11.2 | |
| 186 | Amneal Pharmaceuticals, Inc. | $221,353 | 0.1% | NEW | 58.9 | |
| 187 | Equillium, Inc. | $220,234 | 0.1% | +18% | 27.2 | |
| 188 | Pasithea Therapeutics Corp. | $215,534 | 0.1% | +0% | — | |
| 189 | ENANTA PHARMACEUTICALS INC | $208,711 | 0.1% | -5% | 15.5 | |
| 190 | Surrozen, Inc./DE | $208,076 | 0.1% | +64% | — | |
| 191 | Xeris Biopharma Holdings, Inc. | $206,834 | 0.1% | -22% | 45.5 | |
| 192 | Solid Biosciences Inc. | $201,528 | 0.1% | NEW | — | |
| 193 | Lantheus Holdings, Inc. | $200,396 | 0.1% | NEW | 66.9 | |
| 194 | CYTOKINETICS INC | $197,044 | — | NEW | 28 | |
| 195 | Benitec Biopharma Inc. | $194,970 | 0.1% | -12% | — | |
| 196 | Replimune Group, Inc. | $194,654 | 0.1% | -59% | — | |
| 197 | Larimar Therapeutics, Inc. | $189,558 | 0.1% | NEW | — | |
| 198 | CAPRICOR THERAPEUTICS, INC. | $188,404 | — | +196% | — | |
| 199 | ArriVent BioPharma, Inc. | $187,052 | 0.1% | +2% | — | |
| 200 | Annexon, Inc. | $186,283 | 0.1% | -64% | — | |
| 201 | Ultragenyx Pharmaceutical Inc. | $186,120 | 0.1% | -19% | 31 | |
| 202 | ARGENX SE | $184,753 | 0.1% | -55% | — | |
| 203 | SUTRO BIOPHARMA, INC. | $184,608 | 0.1% | NEW | 30.1 | |
| 204 | KalVista Pharmaceuticals, Inc. | $181,190 | 0.1% | NEW | 25.9 | |
| 205 | ALUMIS INC. | $179,185 | — | NEW | 9.2 | |
| 206 | Unicycive Therapeutics, Inc. | $176,522 | 0.1% | NEW | — | |
| 207 | Forte Biosciences, Inc. | $174,670 | 0.1% | -34% | — | |
| 208 | Tyra Biosciences, Inc. | $173,039 | 0.1% | NEW | — | |
| 209 | BRIGHT MINDS BIOSCIENCES INC. | $168,561 | 0.1% | NEW | — | |
| 210 | ARROWHEAD PHARMACEUTICALS, INC. | $166,845 | 0.1% | NEW | 74.4 | |
| 211 | SPRUCE BIOSCIENCES, INC. | $165,205 | 0.1% | NEW | — | |
| 212 | Certara, Inc. | $163,151 | 0.1% | +124% | 47 | |
| 213 | Relay Therapeutics, Inc. | $162,762 | 0.1% | NEW | 12.7 | |
| 214 | GE HealthCare Technologies Inc. | $159,230 | 0.1% | +17% | 58.2 | |
| 215 | EyePoint, Inc. | $153,959 | — | NEW | 10.3 | |
| 216 | Liquidia Corp | $153,565 | — | NEW | 37.4 | |
| 217 | DHT Holdings, Inc. | $153,212 | 0.1% | NEW | — | |
| 218 | CorMedix Inc. | $149,634 | — | +0% | 75.5 | |
| 219 | UNITED THERAPEUTICS Corp | $141,100 | — | NEW | 80.1 | |
| 220 | Damora Therapeutics, Inc. | $138,254 | 0.1% | NEW | — | |
| 221 | Adagene Inc. | $137,694 | 0.1% | NEW | — | |
| 222 | Solaris Resources Inc. | $137,523 | 0.1% | -39% | — | |
| 223 | NOVO NORDISK A S | $135,424 | 0.1% | NEW | — | |
| 224 | Personalis, Inc. | $133,318 | 0.1% | NEW | 15.7 | |
| 225 | Connect Biopharma Holdings Ltd | $132,957 | 0.1% | +90% | — | |
| 226 | Biohaven Ltd. | $132,490 | — | +50% | — | |
| 227 | AN2 Therapeutics, Inc. | $130,490 | 0.1% | NEW | — | |
| 228 | uniQure N.V. | $128,952 | 0.1% | -28% | — | |
| 229 | Pelthos Therapeutics Inc. | $126,207 | 0.1% | +0% | 25.4 | |
| 230 | MKS INC | $119,501 | 0.1% | NEW | 59.8 | |
| 231 | Avalo Therapeutics, Inc. | $118,216 | 0.1% | -48% | 4.6 | |
| 232 | MANNKIND CORP | $116,115 | 0.1% | -42% | 44.4 | |
| 233 | uniQure N.V. | $114,396 | — | NEW | — | |
| 234 | Lipocine Inc. | $107,402 | 0.0% | -81% | — | |
| 235 | UroGen Pharma Ltd. | $104,716 | 0.0% | -55% | — | |
| 236 | SLB LIMITED/NV | $103,060 | 0.0% | -80% | 63.2 | |
| 237 | CORCEPT THERAPEUTICS INC | $101,904 | 0.0% | -90% | 55.4 | |
| 238 | — | BRIDGEBIO PHARMA INC | $101,757 | 0.0% | +221% | — |
| 239 | ImmunityBio, Inc. | $98,558 | — | NEW | 30 | |
| 240 | Coinbase Global, Inc. | $96,625 | — | NEW | 68 | |
| 241 | GH Research PLC | $95,524 | 0.0% | NEW | — | |
| 242 | Replimune Group, Inc. | $94,054 | — | NEW | — | |
| 243 | Adaptive Biotechnologies Corp | $92,843 | 0.0% | +0% | 35.2 | |
| 244 | Ocugen, Inc. | $91,512 | 0.0% | NEW | — | |
| 245 | Revolution Medicines, Inc. | $90,516 | — | NEW | — | |
| 246 | Corbus Pharmaceuticals Holdings, Inc. | $85,556 | — | NEW | — | |
| 247 | CYTOKINETICS INC | $84,755 | — | NEW | 28 | |
| 248 | CORCEPT THERAPEUTICS INC | $83,878 | — | NEW | 55.4 | |
| 249 | Opus Genetics, Inc. | $81,531 | 0.0% | NEW | — | |
| 250 | Apollo Global Management, Inc. | $75,096 | — | NEW | 55.7 | |
| 251 | ProQR Therapeutics N.V. | $74,629 | 0.0% | +2% | — | |
| 252 | HUYA Inc. | $73,501 | 0.0% | -58% | — | |
| 253 | Invivyd, Inc. | $72,787 | 0.0% | -19% | 25.7 | |
| 254 | Vir Biotechnology, Inc. | $68,515 | — | -5% | 5.6 | |
| 255 | PepGen Inc. | $67,529 | 0.0% | NEW | — | |
| 256 | Yatsen Holding Ltd | $62,065 | 0.0% | +95% | — | |
| 257 | PRECIGEN, INC. | $54,095 | 0.0% | NEW | 38.6 | |
| 258 | SELLAS Life Sciences Group, Inc. | $52,734 | — | -34% | — | |
| 259 | KKR & Co. Inc. | $50,399 | — | NEW | 49.8 | |
| 260 | Upstream Bio, Inc. | $49,455 | 0.0% | -38% | 22.6 | |
| 261 | Voyager Therapeutics, Inc. | $48,523 | — | NEW | 5.5 | |
| 262 | COMPASS Pathways plc | $44,572 | 0.0% | +47% | — | |
| 263 | Monopar Therapeutics | $42,900 | 0.0% | NEW | — | |
| 264 | Structure Therapeutics Inc. | $42,584 | — | NEW | — | |
| 265 | VERTEX PHARMACEUTICALS INC / MA | $41,215 | — | +0% | 76.6 | |
| 266 | Passage BIO, Inc. | $38,897 | 0.0% | NEW | — | |
| 267 | Upstart Holdings, Inc. | $36,002 | — | NEW | 51.7 | |
| 268 | Bloom Energy Corp | $33,195 | 0.0% | -82% | 54.4 | |
| 269 | Rocket Companies, Inc. | $30,947 | — | +262% | — | |
| 270 | IOVANCE BIOTHERAPEUTICS, INC. | $30,047 | — | NEW | 30.6 | |
| 271 | TALPHERA, INC. | $29,105 | 0.0% | +6% | — | |
| 272 | ROCKET PHARMACEUTICALS, INC. | $27,677 | 0.0% | NEW | — | |
| 273 | Ascendis Pharma A/S | $27,075 | — | NEW | 41.5 | |
| 274 | Lyell Immunopharma, Inc. | $26,855 | — | +0% | 3.6 | |
| 275 | PureTech Health plc | $26,139 | 0.0% | +0% | — | |
| 276 | Celcuity Inc. | $19,350 | — | NEW | — | |
| 277 | Janux Therapeutics, Inc. | $19,035 | — | +0% | 24.8 | |
| 278 | Ocugen, Inc. | $18,336 | — | NEW | — | |
| 279 | Ally Financial Inc. | $17,390 | — | NEW | 69.3 | |
| 280 | iShares Bitcoin Trust ETF | $15,649 | — | NEW | — | |
| 281 | Vistagen Therapeutics, Inc. | $15,209 | 0.0% | +0% | — | |
| 282 | CytomX Therapeutics, Inc. | $14,018 | — | NEW | 19.1 | |
| 283 | Merck & Co., Inc. | $12,524 | — | NEW | 70.9 | |
| 284 | Dell Technologies Inc. | $12,449 | — | NEW | 76 | |
| 285 | Marvell Technology, Inc. | $12,049 | — | NEW | 77.3 | |
| 286 | Roivant Sciences Ltd. | $11,068 | — | +0% | — | |
| 287 | DigitalOcean Holdings, Inc. | $10,014 | — | NEW | 73.7 | |
| 288 | Galaxy Digital Inc. | $9,817 | — | NEW | 40.8 | |
| 289 | INOVIO PHARMACEUTICALS, INC. | $8,550 | — | -29% | — | |
| 290 | Cue Biopharma, Inc. | $7,672 | 0.0% | NEW | 23.2 | |
| 291 | Moderna, Inc. | $7,347 | — | NEW | 15.9 | |
| 292 | CORNING INC /NY | $6,744 | — | NEW | 72.7 | |
| 293 | Entera Bio Ltd. | $6,528 | 0.0% | NEW | — | |
| 294 | ALUMIS INC. | $6,069 | — | NEW | 9.2 | |
| 295 | UNITED THERAPEUTICS Corp | $5,619 | — | NEW | 80.1 | |
| 296 | aTYR PHARMA INC | $4,993 | — | +0% | — | |
| 297 | Liquidia Corp | $4,181 | — | NEW | 37.4 | |
| 298 | Super Micro Computer, Inc. | $4,150 | — | NEW | 61.9 | |
| 299 | Avidity Biosciences, Inc. | $3,784 | 0.0% | NEW | 22.3 | |
| 300 | CRISPR Therapeutics AG | $2,724 | — | +5% | 4.5 | |
| 301 | — | ARK ETF TR | $2,610 | — | NEW | — |
| 302 | Karyopharm Therapeutics Inc. | $2,113 | — | NEW | 20.4 | |
| 303 | AppLovin Corp | $2,020 | — | NEW | 86.8 | |
| 304 | Sandisk Corp | $1,972 | — | NEW | 88.8 | |
| 305 | Kodiak Sciences Inc. | $1,844 | — | -99% | — | |
| 306 | CoreWeave, Inc. | $1,251 | — | NEW | 46.5 | |
| 307 | WELLS FARGO & COMPANY/MN | $1,205 | — | NEW | — | |
| 308 | Olema Pharmaceuticals, Inc. | $1,150 | — | -19% | — | |
| 309 | Intellia Therapeutics, Inc. | $632 | — | -5% | 24.5 | |
| 310 | iShares Silver Trust | $504 | — | NEW | — | |
| 311 | ANAVEX LIFE SCIENCES CORP. | $412 | — | +257% | — | |
| 312 | Carnival Corp Ltd. | $378 | — | NEW | — | |
| 313 | Jade Biosciences, Inc. | $344 | — | +0% | — | |
| 314 | Venture Global, Inc. | $338 | — | NEW | 69 | |
| 315 | CHEVRON CORP | $211 | 0.0% | NEW | 54.7 | |
| 316 | — | ISHARES TR | $196 | — | NEW | — |
| 317 | ARBOR REALTY TRUST INC | $154 | — | +0% | — | |
| 318 | IOVANCE BIOTHERAPEUTICS, INC. | $127 | — | NEW | 30.6 | |
| 319 | aTYR PHARMA INC | $122 | — | -22% | — | |
| 320 | Apple Inc. | $23 | — | NEW | 76.1 | |
| 321 | Corvus Pharmaceuticals, Inc. | $11 | — | NEW | — | |
| 322 | Evolus, Inc. | $10 | — | +0% | 30 |
New Positions (146)
Exited Positions (186)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Persistent Asset Partners Ltd including:
Track Persistent Asset Partners Ltd's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Persistent Asset Partners Ltd and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Persistent Asset Partners Ltd
13F Pro is an AI hedge fund tracker and stock research platform. For Persistent Asset Partners Ltd (SEC CIK: 2056052), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Persistent Asset Partners Ltd's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.